Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Surfing the MASH Tsunami
S3-E38.8 - From the Vault: Discussing Patient empowerment at INCBCN 2022
Our week of "Greatest Hits" episodes from the vault concludes with this conversation from the episode discussing the inaugural Innovations in Clinical Care - Barcelona (or INCBCN) conference that convened this past May. This conversation reviews two controversies about the meaning of patient empowerment that arose at the conference.
One key event that 2022 witnessed was the inception of the Innovations in NAFLD Care series, a global effort to discuss clinical care pathways and patient treatment processes in a systematic way. Surfing the NASH Tsunami is a media partner and advocate for this series.
This conversation comes from our review of the conference. The discussion itself is triggered by Roger Green's question about controversies at INCBCN 2022 and addresses two issues. The first is the ongoing controversy over what to call the disease itself. The second addresses the concept of biohacking, which either empowers patients by providing them with extensive data for self-management or disempowers them by divorcing the individual patient's interpretation of this data from disease understanding.